Literature DB >> 15744602

Biological properties of the intervertebral cages made of titanium containing a carbon-carbon composite covered with different polymers.

V Pesáková1, K Smetana, M Sochor, H Hulejová, K Balík.   

Abstract

Intervertebral cages are used in orthopaedics for stabilization of injured lumbar parts of vertebral columns. Our study provides preliminary results of tests of the biological properties of titanium cages with a variously modified carbon/carbon composite (C/C) core. This core was produced from a C/C composite modified by hydrogel materials based on poly(2-hydroxyethyl methacrylate) (HEMA) enriched with 1% collagen or 35% methylmethacrylate or 30% terc-butylmethacrylamide. We evaluated the adhesion of the cells to the tested material coating using an in vitro study of the metabolic activity and cytokine production of the cells (TNF-alpha, IL-8). We studied the biocompatibility of intervertebral cages coated with different copolymers under in vivo condition and in an implantation experiment in the porcine femurs. Both in vitro and in vivo results revealed favourable biotolerance of the use system. Modification of the composite HEMA with the use of collagen seems to have a more positive effect on the new bone tissue formed around the implanted devices than HEMA copolymerized with methylmethacrylate or terc-butylmethacrylamide.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15744602     DOI: 10.1007/s10856-005-5933-7

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  8 in total

1.  Primary stabilizing effect of interbody fusion devices for the cervical spine: an in vitro comparison between three different cage types and bone cement.

Authors:  H J Wilke; A Kettler; L Claes
Journal:  Eur Spine J       Date:  2000-10       Impact factor: 3.134

2.  [The value and limits of intervertebral cages in lumbar arthrodesis].

Authors:  P Gillet
Journal:  Rev Med Liege       Date:  2000-09

3.  Macrophage activation and migration in interface tissue around loosening total hip arthroplasty components.

Authors:  N Ishiguro; T Kojima; T Ito; S Saga; H Anma; K Kurokouchi; Y Iwahori; T Iwase; H Iwata
Journal:  J Biomed Mater Res       Date:  1997-06-05

4.  Biomechanical and biological properties of the implant material carbon-carbon composite covered with pyrolytic carbon.

Authors:  V Pesáková; Z Klézl; K Balík; M Adam
Journal:  J Mater Sci Mater Med       Date:  2000-12       Impact factor: 3.896

5.  Selective bone cell adhesion on formulations containing carbon nanofibers.

Authors:  Rachel L Price; Michael C Waid; Karen M Haberstroh; Thomas J Webster
Journal:  Biomaterials       Date:  2003-05       Impact factor: 12.479

6.  Biological and biochemical properties of the carbon composite and polyethylene implant materials.

Authors:  V Pesáková; K Smetana; K Balík; J Hruska; M Petrtýl; H Hulejová; M Adam
Journal:  J Mater Sci Mater Med       Date:  2003-06       Impact factor: 3.896

7.  Porous titanium-nickel for intervertebral fusion in a sheep model: part 1. Histomorphometric and radiological analysis.

Authors:  Michel Assad; Peter Jarzem; Michel A Leroux; Christine Coillard; Alexandr V Chernyshov; Sylvie Charette; Charles-H Rivard
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2003-02-15       Impact factor: 3.368

Review 8.  Infectious disease transmission through cell, tissue, and organ transplantation: reducing the risk through donor selection.

Authors:  T Eastlund
Journal:  Cell Transplant       Date:  1995 Sep-Oct       Impact factor: 4.139

  8 in total
  2 in total

1.  Biological properties of carbon/carbon implant composites with unique manufacturing processes.

Authors:  Guo-Hui Wang; Shu Yu; Shai-Hong Zhu; Chang-Qing Gao; Yong Liu; Yun-Liang Miu; Bo-Yun Huang
Journal:  J Mater Sci Mater Med       Date:  2009-12       Impact factor: 3.896

2.  Ferulic acid and PDMS modified medical carbon materials for artificial joint prosthesis.

Authors:  Xianlei Gao; Songgang Wang; Yeyang Xu; Hao Li; Hua Zhao; Xin Pan
Journal:  PLoS One       Date:  2018-09-05       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.